Emerging Markets Earnings: Lantus Sighted As Lodestar For Sanofi Board
This article was originally published in PharmAsia News
Executive Summary
Former Sanofi chief executive Chris Viehbacher gives a swan song in the third quarter earnings call that highlighted progress in emerging markets, but not enough on Lantus to save his job as Serge Weinberg made clear the next day.